Design Therapeutics (DSGN) SEC Filings & 10K Form $4.15 +0.08 (+1.94%) As of 12:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Design Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/10/20256:30 AMDesign Therapeutics (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 03/10/20256:10 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/10/20256:16 AMDesign Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 01/13/20258:09 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/06/20256:00 PMDesign Therapeutics (Issuer)Jeffries Sean (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMDesign Therapeutics (Issuer)Shah Pratik (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMBurgess Julie (Reporting)Design Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMDesign Therapeutics (Issuer)LAPPE RODNEY W (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/19/20245:30 PMDesign Therapeutics (Issuer)Prasad Deepa (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/13/20245:53 PMDesign Therapeutics (Subject)Logos Global Management LP (Filed by)Form SC 13D/A08/12/20243:30 PMDesign Therapeutics (Issuer)William Arsani (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/09/20243:20 PMDesign Therapeutics (Subject)Logos SPV 1 LP (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 08/05/20247:01 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/05/20247:12 AMDesign Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/25/20243:30 PMDesign Therapeutics (Filer)Form DEF 14A04/25/20243:33 PMDesign Therapeutics (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CureVac 10Q Form Day One Biopharmaceuticals 10Q Form AbCellera Biologics 10Q Form Phibro Animal Health 10Q Form Gyre Therapeutics 10Q Form Nuvation Bio 10Q Form Cronos Group 10Q Form Evolus 10Q Form Xeris Biopharma 10Q Form LENZ Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:DSGN) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Design Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DSGN Stock Free DSGN Stock Alerts